Stephen Gitelman, MD, leads clinical trials of new treatments for the UCSF, describes new treatment for diabetes as a honeymoon that should never end. The honeymoon he refers to is the initial period after diagnosis. At this point in the disease remaining beta-cells are still functioning well. During this ‘honeymoon’ blood sugars are easier to control, and there is less chance of hypoglycemia or other problems involving blood-sugar levels. He proposes a ‘marriage’ so to say between the newly diagnosed and new treatments that can keep the disease in its honeymoon stage forever.

The article, New Diabetes Treatments Aim for Never-Ending Honeymoon, can be found at the UCSF.edu website. It describes Gitelman’s goals in his new diabetes treatment.  In the beginning of the disease the beta cells are still functioning, just enough to keep blood sugar within range. So, he aims to keep these remaining beta cells functioning with …